Does Ashwagandha Actually Reduce Anxiety and Stress? Here's What the Research Shows

Ashwagandha is one of the most searched supplements in the UK right now, and it is not hard to see why. Stress is near-universal, and the idea that a plant extract could take the edge off has obvious appeal. But between the enthusiastic marketing and the sceptical headlines, it is genuinely difficult to know what the evidence actually says.

The short answer is: yes, there is real evidence that ashwagandha can reduce stress and anxiety markers. Multiple randomised controlled trials and several meta-analyses point in the same direction. But the effect is moderate, not dramatic; it takes weeks rather than days to build, and the quality of the extract matters considerably more than most product descriptions suggest.

This article works through what the studies actually found, where the evidence is weaker than it looks, and what a sensible approach to using ashwagandha looks like in practice.

Key takeaway: Ashwagandha has more clinical backing than most adaptogens. The evidence supports a real, measurable effect on stress and anxiety at the right dose and with the right extract. It is not a substitute for medical treatment, but for everyday stress support, it is one of the better-evidenced options available.

What the Clinical Evidence Actually Shows

The research base for ashwagandha is more substantial than for most herbal supplements. Multiple randomised controlled trials (RCTs) have now been conducted, and several independent research groups have pooled that data into meta-analyses. The overall picture is consistent.

The meta-analysis evidence

A 2024 meta-analysis published in Complementary Therapies in Medicine pooled nine RCTs involving 558 participants and found that ashwagandha produced statistically significant reductions across three key measures compared to placebo:

• Perceived Stress Scale (PSS): mean difference of -4.72 points

• Hamilton Anxiety Scale (HAM-A): mean difference of -2.19 points

• Serum cortisol levels: mean difference of -2.58 units

A 2025 systematic review and meta-analysis published in BJPsych Open covering 15 RCTs and 873 participants found significant reductions in anxiety on the HAM-A scale (SMD -1.55 at baseline, -3.52 at eight weeks), stress on the PSS scale (SMD -4.88), and serum cortisol levels, with the strongest effects observed at doses of 300 to 600 mg per day.

The direction of evidence is clear. Across independent research groups, using different validated scales and different populations, ashwagandha consistently outperforms placebo for stress and anxiety markers.

What individual trials found

The individual RCT data adds useful texture. In one well-cited study, 64 adults with chronic stress received 600 mg per day of KSM-66 ashwagandha root extract for 60 days. The result was a 27.9% reduction in serum cortisol and a 44% reduction in Perceived Stress Scale scores compared to placebo (Chandrasekhar et al., 2012).

The dose finding matters: lower doses do not reliably work. Studies using sub-300 mg doses consistently failed to reach statistical significance. The effective range in KSM-66 trials is 300 to 600 mg per day.

Where the Evidence Is Weaker Than It Looks

The positive findings are genuine, but there are real limitations worth understanding before drawing firm conclusions.

Study size and duration

Most individual RCTs are small. Sample sizes across trials typically range from 60 to 150 participants, and trial durations are short, usually four to twelve weeks. There is no Cochrane systematic review of ashwagandha for anxiety yet, which would represent the highest tier of evidence synthesis.

The cortisol versus perceived stress gap

One finding that often gets overlooked: ashwagandha appears to reduce measurable cortisol levels more reliably than it reduces subjective feelings of stress. A 2025 meta-analysis found significant, measurable reductions in serum cortisol but no consistent effect on perceived stress scores across studies. This is not a reason to dismiss the evidence, but it does suggest the mechanism is physiological rather than purely psychological, and that individual experience may vary.

Extract quality varies enormously

This is the issue most coverage ignores. The trials that produced positive results used KSM-66 - root-only, standardised to a minimum of 5% withanolides. Many products on the market use whole root powder with no standardisation, which contains far lower concentrations of the active compounds.

KSM-66 standardised to at least 5% withanolides appears necessary for consistent stress benefits. A product listing "ashwagandha root powder" with no standardisation information is not equivalent.

The population question

The majority of trials to date recruited participants from India, and most enrolled adults with either self-reported high stress or a confirmed anxiety diagnosis. The extent to which findings translate to healthy UK adults with everyday, lower-level stress is not fully established. The direction of evidence is still supportive, but the effect size may differ.

How Ashwagandha Works on Stress

Understanding the mechanism helps set realistic expectations.

Ashwagandha is classified as an adaptogen: a compound thought to support the body's ability to manage physiological stress responses. Its primary active compounds are withanolides, a group of steroidal lactones concentrated in the root. These compounds appear to act on the hypothalamic-pituitary-adrenal (HPA) axis, which is the system that governs the body's cortisol release in response to stress.

The working model, supported by published research, involves three mechanisms:

1. HPA axis regulation - moderating the cortisol response to perceived stressors

2. GABA signalling modulation - similar in direction (though not mechanism) to how some anti-anxiety compounds work

3. Reduction of inflammatory markers - chronic stress is associated with elevated inflammation, and ashwagandha appears to reduce certain inflammatory biomarkers

The practical implication of this mechanism is important: Ashwagandha does not work acutely. It is not comparable to taking a painkiller and feeling relief within an hour. The cortisol-recalibration process takes time. Most trials showing significant results ran for at least eight weeks, and the 2026 dose-response meta-analysis found effects became statistically significant at the eight-week mark specifically. Assessing results at three or four weeks is too early to conclude.

What to Look For in an Ashwagandha Supplement

Given how much the extract quality affects outcomes, this is the most practically important section for anyone considering a purchase.

Extract type and standardisation

KSM-66 is the most clinically researched ashwagandha extract for stress and anxiety. It is derived from the root only and standardised to a minimum of 5% withanolides - the active compounds responsible for the observed effects.

Generic root powder with no standardisation information is not equivalent to KSM-66 and is unlikely to deliver the doses used in clinical trials.

Dose

The evidence points clearly to 300 to 600 mg per day of a standardised extract. The research provisionally recommends 300 to 600 mg of root extract standardised to 5% withanolides for generalised anxiety, though they note more data is needed before issuing a stronger recommendation. The dose-response data suggest that 600 mg per day produces more consistent outcomes than 300 mg, though both are within the effective range.

Duration

Plan for a minimum of eight weeks before evaluating results. This is not a product that delivers acute relief. The mechanism is gradual recalibration of the stress response system, not immediate symptom suppression. The BJPsych Open meta-analysis found that effects on both cortisol and PSS scores became statistically significant, specifically at the eight-week mark.

Safety considerations

Ashwagandha appears well-tolerated for up to three months of use, with clinical trials reporting mostly mild and infrequent side effects. However, the long-term safety profile beyond three months is not well established. It may not be appropriate for:

• People who are pregnant or breastfeeding

• Individuals with thyroid conditions
  

If you are taking any prescribed medication, speak to a GP before adding ashwagandha.

The Verdict

Ashwagandha is not a miracle supplement, and it is not a placebo either. The clinical evidence places it in a genuinely useful middle ground: well above the level of most herbal products, but short of the certainty that would come from larger, longer trials.

The evidence supports using it for everyday stress and anxiety support, at the right dose, with a standardised extract, over a sustained period. The key variables are:

• Extract: KSM-66, standardised to a minimum 5% withanolides

• Dose: 300 to 600 mg per day

• Duration: Minimum eight weeks to assess effect

What the evidence does not support is treating ashwagandha as a substitute for professional support if anxiety is significantly affecting daily life. If stress or anxiety is persistent or severe, speaking to a GP is the right first step.

For people dealing with everyday, background-level stress and looking for a well-evidenced supplement option, ashwagandha is one of the more credible choices available. The research is not perfect, but it is consistent, and that matters.